See more : Atlas Estates Limited (ATL.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Rainbow Children’s Medicare Limited (RAINBOW.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rainbow Children’s Medicare Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ares Management Corporation (ARES-PA) Income Statement Analysis – Financial Results
- Taewoong Co.,Ltd (044490.KQ) Income Statement Analysis – Financial Results
- Finolex Industries Limited (FINPIPE.NS) Income Statement Analysis – Financial Results
- Jutal Offshore Oil Services Limited (3303.HK) Income Statement Analysis – Financial Results
- Sato Sangyo Co., Ltd. (3450.T) Income Statement Analysis – Financial Results
Rainbow Children's Medicare Limited (RAINBOW.NS)
About Rainbow Children's Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.97B | 11.74B | 9.74B | 6.40B | 7.07B | 5.33B |
| Cost of Revenue | 3.66B | 1.58B | 1.95B | 1.03B | 1.05B | 802.13M |
| Gross Profit | 9.31B | 10.15B | 7.79B | 5.37B | 6.02B | 4.52B |
| Gross Profit Ratio | 71.76% | 86.51% | 80.00% | 83.86% | 85.11% | 84.94% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 147.93M | 2.72B | 2.04B | 1.65B | 1.74B | 1.32B |
| Selling & Marketing | 290.24M | 272.90M | 215.10M | 90.49M | 140.63M | 113.54M |
| SG&A | 3.36B | 3.02B | 2.27B | 1.75B | 1.88B | 1.43B |
| Other Expenses | 0.00 | 308.65M | 189.37M | 4.77M | 2.82B | 2.18B |
| Operating Expenses | 3.36B | 7.09B | 5.57B | 4.45B | 4.70B | 3.61B |
| Cost & Expenses | 7.02B | 8.67B | 7.52B | 5.48B | 5.76B | 4.41B |
| Interest Income | 204.43M | 298.57M | 114.67M | 90.41M | 98.76M | 68.61M |
| Interest Expense | 625.30M | 551.95M | 532.03M | 432.44M | 446.06M | 387.99M |
| Depreciation & Amortization | 1.12B | 902.68M | 832.63M | 733.38M | 694.11M | 603.16M |
| EBITDA | 4.69B | 4.30B | 3.27B | 1.75B | 2.11B | 1.60B |
| EBITDA Ratio | 36.20% | 36.41% | 33.25% | 26.90% | 29.35% | 29.19% |
| Operating Income | 5.95B | 3.09B | 2.22B | 894.96M | 1.28B | 913.00M |
| Operating Income Ratio | 45.85% | 26.35% | 22.77% | 13.98% | 18.05% | 17.14% |
| Total Other Income/Expenses | -3.00B | -2.60B | -2.30B | -386.83M | -381.81M | -337.74M |
| Income Before Tax | 2.95B | 2.82B | 1.87B | 556.96M | 933.56M | 575.26M |
| Income Before Tax Ratio | 22.73% | 24.01% | 19.24% | 8.70% | 13.20% | 10.80% |
| Income Tax Expense | 765.26M | 694.02M | 486.73M | 161.28M | 380.16M | 129.36M |
| Net Income | 2.17B | 2.11B | 1.38B | 400.18M | 553.40M | 445.90M |
| Net Income Ratio | 16.73% | 17.97% | 14.20% | 6.25% | 7.83% | 8.37% |
| EPS | 21.38 | 20.89 | 14.75 | 4.36 | 6.07 | 4.39 |
| EPS Diluted | 21.33 | 20.89 | 14.40 | 4.25 | 5.92 | 4.39 |
| Weighted Avg Shares Out | 101.50M | 100.95M | 93.42M | 91.84M | 91.84M | 101.51M |
| Weighted Avg Shares Out (Dil) | 101.76M | 100.95M | 95.70M | 94.13M | 94.13M | 101.51M |
Source: https://incomestatements.info
Category: Stock Reports